Scopus Asset Management’s Evolv Technologies EVLV Stock Holding History

Scopus Asset Management’s Portfolio EVLV Stock Details EVLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-200,000	Closed	-$890K	–	277
2021 Q4	$890K	Hold	200,000	–	–	0.02%	268
2021 Q3	$1.2M	Buy	+200,000	New	+$1.59M	0.02%	319

Other funds holding EVLV

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return

Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Scopus Asset Management's EVLV Position: Q1 2022 in Review

Scopus Asset Management sold out of Evolv Technologies (EVLV) in Q1 2022, closing a stake of 200,000 shares — an estimated $890K sold.

Scopus Asset Management first reported a position in EVLV in Q3 2021 and held it in 2 quarters. The position peaked at $1.2M in Q3 2021. 87 funds tracked by Wall St. Rank hold EVLV as of Q1 2022.

Scopus Asset Management reported no remaining Evolv Technologies position as of Q1 2022 after selling out during the quarter.
Scopus Asset Management sold 200,000 Evolv Technologies shares in Q1 2022, an estimated $890K.
Scopus Asset Management first reported a position in Evolv Technologies in Q3 2021 and held it in 2 quarters.
Scopus Asset Management's Evolv Technologies position peaked at $1.2M in Q3 2021.
87 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2022.

Based on Scopus Asset Management's 13F filing for Q1 2022, filed 16 May 2022.